AstraZeneca shareholder BlackRock has urged the British pharma giant's board to eventually re-engage in talks with Pfizer over a possible deal, but backed its rejection of Pfizer's offer this week, according to people familiar with the situation.
from WSJ.com: US Business http://ift.tt/1ob1y8k
via IFTTT
from WSJ.com: US Business http://ift.tt/1ob1y8k
via IFTTT
No comments:
Post a Comment